首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Therapeutische umschau

缩写:

ISSN:0040-5930

e-ISSN:1664-2864

IF/分区:0.2/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引8115
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Roy Frei,Benjamin Misselwitz Roy Frei
Crohn's disease (CD) is a chronic inflammatory bowel disease that can affect the entire gastrointestinal tract. The pathophysiology of CD includes a disrupted interplay of intestinal bacteria, the intestinal immune system and the intestinal...
Selina N Späni,Tarun Mehra,Kanchan Dongre et al. Selina N Späni et al.
Oral anticancer therapies offer various advantages but also entail risks due to their toxicity and narrow therapeutic ranges. Since these drugs are increasingly prescribed in patients with existing polypharmacy, identifying and assessing po...
Helena Marie Stricker,Andreas Wicki Helena Marie Stricker
The use of immune checkpoint inhibitors has fundamentally changed the treatment landscape of solid tumors in recent years. Even in advanced stages or in tumors with historically poor prognosis, such as triple-negative breast cancer, progres...
Vérène Dougoud-Chauvin Vérène Dougoud-Chauvin
Cancer is a disease of old age with approximately 50% of new cancer cases occurring in humans aged 65 years and older and this number is expected to rise to 58% by 2030. Chemotherapy remains a standard part of cancer treatment, alongside ne...
Christian Diehl,Sacha Rothschild Christian Diehl
Since the development of the first immune checkpoint inhibitor, a new era in tumour immunotherapy has been initiated and response and survival rates have improved in many tumour entities. Despite this encouraging progress, the number of pat...
Julia Landin,Walter Paul Weber,Marcus Vetter Julia Landin
Breast cancer today has a significantly better prognosis than two to three decades ago. Treatment options have improved significantly. However, new systemic therapy has also resulted in side effects that clinicians must first become familia...
Heinz Läubli Heinz Läubli
The advent of immunotherapy has brought about a revolutionary shift in the treatment of cancer patients, significantly improving their outcomes. However, it is disheartening that not all patients can benefit from the currently available imm...
Luzius Müller Luzius Müller
Work in the field of intercultural communication initially assumed negotiations between 'culturally homogeneous' delegations. In the clinical field, it became apparent that 'cultural homogeneity' cannot be assumed, especially in the 'party'...